abstract BACKGROUND AND OBJECTIVE: Propofol is commonly used in pediatric sedation, which may cause hypotension during induction. Our goal was to determine the effect of a preinduction 20-mL/kg isotonic fl uid bolus on propofol-induced hypotension, assess clinical signs of hypoperfusion during hypotension, and evaluate for age-related propofol dosing differences.
A Presedation Fluid Bolus Does Not Decrease the Incidence of Propofol-Induced Hypotension in Pediatric Patients
Pediatric patients may have diffi culty remaining immobile for prolonged, painless procedures such as MRI and auditory brainstem-evoked response (ABR) testing, necessitating the use of procedural sedation. The favorable properties of propofol, including rapid onset of action, short recovery time, and minimal residual effects, have led to a signifi cant increase in its use by nonanesthesiologists for sedation in multiple diagnostic and therapeutic procedures in children. [1] [2] [3] [4] [5] The adverse cardiovascular depressant effects of propofol in children are well documented, and induction often results in systolic and diastolic blood pressure reductions of 15% to 40% from preinduction values. [5] [6] [7] [8] [9] [10] [11] Anesthesiologists often use a 20% to 30% decrease from baseline systolic blood pressure in the pediatric surgical patient as a cutoff for hypotension, but there is a lack of consensus in this defi nition. 12 Pediatric hypotension is more commonly defi ned by using the patient's ®
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86 | VOLUME 5 • ISSUE 2 www.hospitalpediatrics.org age, height, and weight percentiles as in the Pediatric Advanced Life Support (PALS) guidelines. 13 In the pediatric patient, the potential reduction in blood pressure with propofol induction may be signifi cant enough to result in clinical signs of hypoperfusion, thus raising concern about a possible temporary decrease in end organ perfusion. The effect of hypotension in the neonate and in children with trauma or sepsis has been extensively studied, but very few studies address hypotension in healthy children undergoing sedation or general anesthesia. Because there are no good data supporting a safe low blood pressure cutoff in children, the present literature supports preventing and treating hypotension secondary to anesthetic agents. 14 Outcomes of hypotension secondary to anesthesia have been studied in adults, and a greater postoperative length of stay and greater mortality at 1 year were found. 15, 16 The adult patients with secondary events had a higher American Society of Anesthesiologists (ASA) classifi cation and a lower baseline blood pressure, however. Other studies in the adult population have investigated preinduction treatments to prevent hypotension during propofol induction, including the use of isotonic fl uids, 17, 18 Hetastarch, 19 ephedrine, 12, 20, 21 phenylephrine, 22 dopamine, dobu tamine, 20 ketamine, [23] [24] [25] and calcium chloride. 26 However, little research has been conducted specifi cally to determine whether there is a signifi cant risk to the pediatric patient during propofolinduced hypotension or whether there is an effective method to prevent the reduction in blood pressure associated with propofol induction in this patient population.
We hypothesized that a preinduction 20-mL/kg isotonic saline bolus would decrease the incidence of propofolinduced hypotension. The purpose of our randomized controlled trial was to evaluate our hypothesis during procedural sedation in ped iatric patients. Other objectives were to assess for clinical signs of hypoperfusion in the hypotensive patients and to measure differences in propofol dosing in relation to age, because earlier studies suggested that a larger milligram per kilogram amount might be needed in infants than in children. The procedural sedation for MRI or ABR with propofol was performed under the direct supervision of a pediatric intensivist or hospitalist. Multiple syringes containing 1 mg/kg of propofol were prepared by the sedation nurse before the start of the procedure, which allowed easy dose administration and calibration. Patients were then placed on the cardiorespiratory monitor with pulse oximetry before administration of the loading dose of propofol. All patients received 1 mL of 1% lidocaine intravenously before propofol induction to reduce the pain associated with propofol administration. Propofol manufacturers suggest 2.5 to 3.5 mg/kg to be given over 30 seconds for induction in pediatric patients 11 ; therefore, propofol was administered in incremental doses of 1 mg/kg for induction, with a maximum dose of 6 mg/kg. Induction was considered complete when the patient was asleep, unresponsive to verbal or gentle tactile stimulation, and with intact cardiorespiratory drive. Propofol infusion was continued with the hourly infusion rate equal to the dose needed for induction. Thus, if a patient required three 1-mg/kg boluses of propofol to achieve adequate sedation, then the infusion rate would be started at 3 mg/kg per hour. This dosing protocol was routinely used at our institution before the commencement of our study because it was effective at keeping the patients adequately sedated for the duration of the required procedure.
Once the patient was sedated, a nasal cannula was placed in the nostrils to deliver supplemental oxygen in the event a desaturation occurred and to allow monitoring of end-tidal carbon dioxide. All patients were monitored continuously for heart rate, respiratory rate, oxygen saturations with pulse oximetry, and end-tidal carbon dioxide levels. Blood pressure was measured via an automated blood pressure monitor (MEDRAD Veris MR; MEDRAD, Inc, Warrendale, PA), with an appropriately sized cuff, once before induction, once immediately after induction, and at 5-minute intervals thereafter until the patient was awake and alert after the procedure, when the fi nal recovery blood pressure was obtained.
Hypotension Protocol
A priori, hypotension was defi ned as a systolic blood pressure of ≤70 mm Hg for ages 6 months to 1 year and, in patients >1 year old, a systolic blood pressure of <70 + (age × 2) mm Hg, as defi ned in PALS guidelines. 13 Patients with documented hypotension were examined physically for signs of hypoperfusion in the lower extremities, including capillary refi ll >3 seconds, presence of cool extremities, and decreased dorsalis pedis or posterior tibial arterial pulses. For patients with systolic hypotension without signs of peripheral hypoperfusion, the propofol infusion rate was reduced by 0.5 mg to 1 mg/kg per hour at the discretion of the physician every 5 minutes until the hypotension resolved. If a patient had continued hypotension despite 2 reductions in the propofol infusion rate, a 20-mL/kg isotonic saline bolus was administered and blood pressure was reassessed; the procedure was resumed with the resolution of the hypotension. For patients with signs of hypoperfusion, the patient was given a 20-mL/kg normal saline IV bolus and the propofol infusion rate was decreased by 0.5 mg to 1 mg/kg per hour at the discretion of the physician every 5 minutes until the signs of hypoperfusion resolved. If hypotension or hypoperfusion persisted despite the isotonic saline bolus and the reduction in propofol infusion rate, the MRI or ABR was aborted, and the procedure was rescheduled with the department of anesthesia.
Statistical Methods
The data was entered into a Microsoft Excel (Microsoft, Redmond, WA) spreadsheet, verifi ed by the authors, and analyzed using SPSS 17.0 (IBM SPSS Statistics, IBM Corporation) based on the intent to treat. In each group, the systolic and diastolic blood pressure values were averaged during 3 time intervals: preinduction, lowest during the procedure (lowprocedural), and recovery. Although serial BP measurements were obtained every 5 minutes after induction, for the purpose of statistical analysis the single lowest BP reading was used as the low procedural value. Nominal variable differences for 2 groups were determined by χ 2 and by t tests for scalar variables. Repeated-measures differences between 2 groups for interval variables were tested with mixed effect regressions. Two-sided P values <.05 were considered signifi cant.
RESULTS
Between December 2006 and January 2008, 157 patients between the ages of 6 and 60 months who were scheduled for MRI or ABR testing with procedural sedation were approached for enrollment. The study was stopped after 14 months due to slow enrollment and because of the delays in the MRI schedule that was created when a treatment patient received the preprocedure IV bolus.
Thirty-one parents or legal guardians declined their child's participation in the study, leaving 126 subjects randomly assigned to the experimental and control conditions. The use of a randomization table resulted in an unequal distribution of patients between groups: 52 treatment and 74 control. Patient demographics are provided in Table 1 . Two oncology patients without active disease, 1 in each arm, were the only ASA category III study participants. There was no signifi cant difference in race, gender, age, weight, ASA class, BMI, or NPO time between groups.
Systolic and diastolic blood pressures decreased signifi cantly (P < .001) after propofol induction in both groups. and diastolic blood pressures were not signifi cantly different between treatment and control groups (systolic P = .46, diastolic P = .76), demonstrating no effect from the preinduction isotonic fl uid bolus.
Twenty-six patients, 12 (23.1%) in the treatment group and 14 (18.9%) in the control group, had ≥1 documented reading of hypotension, which were not statistically different (Fisher's exact P = .66). The average total dose of propofol was slightly higher in the treatment group, but the difference was also not signifi cant (10.4 ± 5.5 mg/kg vs 8.2 ± 4 mg/kg; P = .26). Four patients experienced hypotension during induction, and the other patients had hypotension at various times after induction through the end of the procedure. Hypotension resolved in 24 of the 26 patients with a reduction in their propofol infusion rate, and 1 patient from each arm received a 20-mL/kg isotonic saline bolus for persistent hypotension despite a reduction in their propofol infusion rate. None of the 26 patients who developed propofol-induced hypo tension had clinical signs of hypoperfusion, and all patients successfully completed the procedure and recovered without complications. Last, when we controlled for procedure time, patients ≤12 months old (n = 9) needed a signifi cantly larger average total amount of propofol than patients >12 months of age (n = 117) (11.29 ± 5.59 mg/kg vs 6.83 ± 3.37 mg/kg, respectively; P = .04).
DISCUSSION
The positive attributes of propofol have generated a signifi cant increase in its use for pediatric sedation, and its hypotensive effects have been well documented. [5] [6] [7] [8] [9] [10] [11] However, there has been little research to determine whether there is a signifi cant risk to the pediatric patient from propofol-induced hypotension or whether there is an effective method to prevent the induced hypotension, thus prompting this study.
This was the fi rst prospective, randomized, controlled trial in the pediatric population to test a nondrug intervention to attenuate the hypotensive effects of propofol during induction.
* Although the presedation bolus did not demonstrate an effect in this study, our study did demonstrate Data presented as percentages or means ± SDs.
FIGURE 1
Differences in systolic blood pressure. * A presubmission PubMed search using the words propofol and hypotension in the title search fi lter did not reveal any studies of this type in the pediatric population.
the ease of reversing propofol-induced hypotension by decreasing the infusion rate by 0.5 to 1 mg/kg per hour, which resulted in immediate blood pressure improvement without the use of additional measures. The low blood pressures in the hypotensive patients were an average of 4.3 mm Hg below the PALS threshold for hypotension. Our study was not designed to assess for possible long-term effects from the propofol-induced hypotension, but it does add to the current literature indicating that using the PALS guidelines as a threshold to assess and treat transient hypotension secondary to propofol is safe in the short term.
The decrease in blood pressure secondary to propofol induction is caused by direct and indirect vasodilation and myocardial depression. 8,9,27-32 The 20-mL/kg isotonic fl uid bolus was used because it is the standard IV fl uid bolus amount provided during resuscitative efforts in pediatric patients, 13 but it was not suffi cient to counter the vasodilatory and myocardial depressive effects of propofol. As suggested by Hertzog et al, 5 a calculated preprocedure fl uid defi cit could be provided before or during the procedure, which may decrease the incidence of propofolinduced hypotension. This raises the question of what effect NPO status had on the development of hypotension. An adult study by Morley et al 33 did not fi nd a relationship to fl uid abstinence and hypotension during propofol induction. However, Nafi u et al 14 noted that older children who were able to maintain a longer NPO status before surgery were more likely to become hypotensive after anesthetic induction. In our study, the hypotensive and normotensive patients had a similar NPO time, but the NPO status was not stratifi ed into liquids, formula, or solids that would have allowed additional breakdown of the data.
Clinical impression of diminished distal pulses, prolonged capillary refi ll time, skin color, and decreased extremity temperature were evaluated when concern for hypoperfusion was present. There was no evidence of hypoperfusion in the subjects who experienced propofol-induced hypotension by the aforementioned criteria, a fi nding that is consistent with previous studies. 5, 34 The aforementioned physical signs are subjective measures, however, with signifi cant interrater variability, which reduces their reliability.
The average procedure time for MRI was 12 minutes longer than for ABR, and thus the continuous infusion of propofol was longer in the patients undergoing MRI. Twenty-four of the 26 hypotensive patients underwent MRI, which could account for the increased total amount of propofol in the hypotensive patients. Neonates and young infants have a high total body water to body fat ratio, which results in a larger peripheral volume of distribution for lipophilic medications such as propofol. [35] [36] [37] The large peripheral volume of distribution may be the reason that patients in our study, ≤1 year of age, needed signifi cantly more propofol per kilogram than patients >1 year of age.
There are multiple limitations to our study, the most signifi cant being the early termination of the study before we achieved the desired sample size because of slow enrollment and the effect the study was having on the MRI schedule. Because of this limitation, a post hoc sample size calculation was performed to establish the sample size that would have been needed to detect a clinically signifi cant change in the incidence of propofol-induced hypotension. Using our low systolic blood pressure population mean of 81.5 mm Hg and SD of 9, with a power of 80% and α of .05, we calculated a substantially smaller sample size of 7 per group to be adequate to detect a meaningful change. We believe the much larger, originally projected sample size probably refl ected an overestimation of the SD of the sample. Although this new information was performed post hoc, we think it provides additional evidence that our interpretation of no signifi cant difference between groups is valid.
Comprehensive data on patients who did not participate in the study were not collected for comparison. The unequal random assignment of subjects into the control and treatment groups was also unfortunate and probably a consequence of discontinuing the study earlier than planned. Blocked randomization may have eliminated this problem, or had the duration of the study continued as originally planned, the inequality in group number probably would had been much less or eliminated.
NPO status could have been further stratifi ed, which may have uncovered a relationship to the duration of abstinence from fl uid intake and propofol-induced hypotension. The traditional assessment of blood pressure by using a cuff can be less accurate, and therefore using this device as a trigger to assess for hypoperfusion is suboptimal. Invasive hemodynamic monitoring would be ideal to determine hypotension and trigger an assessment for hypoperfusion, but such monitoring was not practical in a research study involving an outpatient procedure. Finally, this was a single-center study, which can infl uence bias.
CONCLUSIONS
The administration of a presedation 20-mL/kg isotonic saline bolus did not decrease the incidence of propofolinduced hypotension in our study, contrary to our hypothesis. Additional studies are needed to determine the utility of a presedation bolus before propofol induction. By using the PALS threshold for hypotension, we did not fi nd evidence of short-term adverse effects from the propofol-induced hypotension, nor did we fi nd evidence of hypoperfusion in our hypotensive patients by using the defi ned subjective assessments. Propofolinduced hypotension can readily be reversed with a small reduction in the propofol infusion rate. Children <1 year of age need a signifi cantly larger amount of propofol per kilogram than older children.
